Purpose: To establish a gemcitabine-resistant lung adenocarcinoma cell line, A549/G+, and to screen the differences of miRNA expression in exosomes from A549 and A549/G+ cells. Methods: A549 cells were exposed in gemcitabine until they were resistant to gemcitabine, and extracted exosomes from A549 and A549/G+. The RNAs from exosomes were subjected to miRNA expression microarray experiments. Results: After 39 weeks of continuous induction, we induced drug resistance in A549 cells. The resistance index was 6. Via GeneChip miRNA 4.0 analysis, there were 446 differential miRNAs between A549 and A549/G+. Target gene prediction and pathway analysis discovered the microRNAs in the intersections may participate in drug resistance. Conclusion: These differential miRNAs help to do in-depth research to elucidate the mechanism of resistance to gemcitabine in non-small cell lung cancer.
CITATION STYLE
Liang, A. L., Du, S. L., Zhang, B., Zhang, J., Ma, X., Wu, C. Y., & Liu, Y. J. (2019). Screening miRNAs associated with resistance gemcitabine from exosomes in A549 lung cancer cells. Cancer Management and Research, 11, 6311–6321. https://doi.org/10.2147/CMAR.S209149
Mendeley helps you to discover research relevant for your work.